Optimal risk assessment intervals for primary prevention of cardiovascular disease: a population-based two-stage landmarking study

Our evidence suggests that CVD risk assessment intervals for primary prevention should be stratified by sex, initial risk level and age. For the UK population, our method found risk assessment intervals that reduce the number of assessments required while shortening the waiting time to the next assessment for those most in need.

Authors

Institutions

Publication Details

Journal
BMJ Public Health
Published
2025-01-01
DOI
https://doi.org/10.1136/bmjph-2024-001241
Citations
2
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
4.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimal risk assessment intervals for primary prevention of cardiovascular disease: a population-based two-stage landmarking study

Francesca Gasperoni, Angela Wood, Emanuele Di Angelantonio, Matthew Arnold et al.
2 citations
BMJ Public Health
Lipoproteins and Cardiovascular Health
4.01
article

Optimal risk assessment intervals for primary prevention of cardiovascular disease: a population-based two-stage landmarking study

Francesca Gasperoni, Angela Wood, Emanuele Di Angelantonio, Matthew Arnold, Z. Gu, Michael Sweeting, Ellie Paige, Juliet A. Usher‐Smith, Jessica Barrett, Katrina Poppe, David Stevens
article en
2 citations

Abstract

Our evidence suggests that CVD risk assessment intervals for primary prevention should be stratified by sex, initial risk level and age. For the UK population, our method found risk assessment intervals that reduce the number of assessments required while shortening the waiting time to the next assessment for those most in need.

BMJ Public HealthVol. 3(1)
Australian National University (AU), University of Leicester (GB), University of Auckland (NZ), The University of Queensland (AU), QIMR Berghofer Medical Research Institute (AU), University of Cambridge (GB), British Heart Foundation (GB), National Institute for Health and Care Research (GB), Human Technopole (IT), MRC Biostatistics Unit (GB), Health Data Research UK (GB)
Scottish Government, National Institute for Health and Care Research, British Heart Foundation, Department of Health and Social Care, National Heart Foundation of Australia, National Heart Foundation of New Zealand, Public Health Agency, Chief Scientist Office, Scottish Government Health and Social Care Directorate, Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Health and Social Care Research and Development Division, NIHR Cambridge Biomedical Research Centre
Openalex Percentile: Top 8%
Lipoproteins and Cardiovascular Health
4.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.